Copyright
©The Author(s) 2016.
World J Gastroenterol. Mar 28, 2016; 22(12): 3341-3354
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3341
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3341
Clinicopathologic parameters | Frequency | % |
All cases | 30 | |
Gender | ||
Male | 23 | 76.7 |
Female | 7 | 23.3 |
Age (yr) | ||
< 50 | 5 | 16.7 |
> 50 | 25 | 83.3 |
Tumor size (cm) | ||
< 5 | 8 | 26.7 |
> 5 | 22 | 73.3 |
Serum HBsAg | ||
Positive | 24 | 80.0 |
Negative | 6 | 20.0 |
Serum AFP (ng/mL) | ||
< 25 | 4 | 13.3 |
> 25 | 26 | 86.7 |
Cirrhosis | ||
Presence | 27 | 90.0 |
Absence | 3 | 10.0 |
UICC stage | ||
I + II | 13 | 43.3 |
III + IV | 17 | 56.7 |
Metastasis/Recurrence | ||
Yes | 18 | 60.0 |
No | 12 | 40.0 |
Edmondson grade | ||
Low (I/II) | 10 | 33.3 |
High (III/IV) | 20 | 66.7 |
- Citation: Peng R, Zhao GX, Li J, Zhang Y, Shen XZ, Wang JY, Sun JY. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo. World J Gastroenterol 2016; 22(12): 3341-3354
- URL: https://www.wjgnet.com/1007-9327/full/v22/i12/3341.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i12.3341